ZenBio and CELLnTEC Partner to Expand Reach in Epithelial Cell Culture Market

Research Triangle Park, NC, November 1, 2009 – CELLnTEC Advanced Cell Systems (www.cellntec.com) of Bern, Switzerland, leaders in epithelial progenitor cell targeted in vitro culture tools, announces ZenBio, Inc. (www.zenbio.com) of Research Triangle Park, North Carolina as their strategic distribution partner for North America. Customers will now have access to the entire CELLnTEC cell culture portfolio via ZenBio, Inc. This strategic partnership will ensure a reliable

supply of CELLnTEC products with next day delivery for most North American research customers from the ZenBio facility in Research Triangle Park. It will enable both parties to leverage their respective cell culture expertise to deliver worldclass customer service and technical resources to accelerate discovery in epithelial biology. “We are very excited about this partnership with CELLnTEC and believe it is a good strategic fit for both companies building on complimentary portfolios in the primary cells market to drive growth and serve North American research customers more effectively”,

remarked Peter Pieraccini, President and CEO of ZenBio, Inc.

CELLnTEC Advanced Cell Systems specializes in the development of progenitor cell targeted in vitro tools for epithelial research. Founded in 2002, CELLnTEC uses its novel adult stem cell-based approach to develop culture media that specifically target and retain epithelial progenitor cells in vitro. As of result of this unique approach to epithelial tissue culture media, these products deliver significant improvements in isolation, growth, and modeling accuracy. In addition, CELLnTEC also provides a range of human and animal epithelial cells in vitro models for researchers in academic, biotech and pharma institutions, and is actively continuing the development of additional progenitor cell targeted culture media and organotypic in vitro 3D models. For more information, please see www.cellntec.com.

About ZenBio, Inc.

Zen-Bio, Inc. (ZB) is a leading global provider of advanced cell-based solutions and services to the life science, cosmetics, and personal care communities. The company, founded in 1995, was a pioneer in adipose derived stem cells (ASCs) and continues this legacy providing cutting edge human primary cell culture products and services. Our mission is to provide the highest quality human cell systems, reagents and contract services to our research partners, to develop and commercialize innovative research tools, leverage our expertise through research and development and strategic alliances, and accelerate discovery.

For more information, contact:

Will Plentl, Director of Business Development

ZenBio, Inc.

Tel. (919)-547-0692; or 1-866-ADIPOSE

Email: will@zenbio.com

www.zenbio.com

3200 Chapel Hill-Nelson Blvd. Suite 104 • P.O. Box 13888 • RTP, NC 27709 www.zenbio.com

< | >